Clinical Trials Directory

Trials / Completed

CompletedNCT01065220

Sex Steroids and the Serotonin Transporter

The Influence of Sex Steroid Hormones on Serotonin Transporter Binding in the Human Brain Investigated by Positron Emission Tomography

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to prove the influence of the sex steroid hormones estrogen, progesterone and testosterone on the serotonin transporter (5-HTT) binding using positron emission tomography (PET) and the selective radioligand \[11C\]DASB. Specifically, the 5-HTT binding will be quantified before and after hormone therapy underwent by 10 male-to-female (MtF) and 10 female-to-male (FtM) transsexuals urging for hormone treatment. The high-level, long-term administration of opsite sex steroid hormones in transsexuals provide the unique opportunity to investigate the influence of sex steroid hormones on the serotonergic system. Since the serotonin transporter serves as a primary target molecule for antidepressant treatment, the results of the study will be of benefit for the assessment of the clinical relevance of estrogen and testosterone as modulatory and neuroactive agents.

Conditions

Interventions

TypeNameDescription
DRUGTestolactone undecanoate4ml i.m.
DRUGLynestrenol2/day
DRUGCyproterone Acetate50mg per day
DRUGEstradiol100 microgram TTS twice a week
DRUG5-alpha reductase inhibitor1mg daily

Timeline

Start date
2010-02-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2010-02-09
Last updated
2014-01-03

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01065220. Inclusion in this directory is not an endorsement.